Bellicum Pharmaceuticals Analyst and Investor Meeting at ASH

San Diego, CA, December 3, 2018
RSVP for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

Bellicum Pharmaceuticals Inc. [BLCM] US$186 MM MCap
De­vel­op­ing cell ther­a­pies with molec­u­lar switch tech­nol­o­gy and co-stim do­mains en­abling phar­ma­co­log­ic con­trol over cells for en­hanced ef­fi­ca­cy and safe­ty. Lead (reg­is­tra­tio­n­al EU) pro­gram is a Ph2 for... [more in­for­ma­tion]